跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,844 条关于
“Invasive Candidiasis”
全部
9,844
临床试验
7,221
药物
29
机构
22
资讯
2,572
去年
Basilea's Fosmanogepix Enters Phase 3 for Invasive Candidiasis Treatment
2年前
T2 Biosystems' T2Candida Panel Receives FDA Clearance for Pediatric Use
去年
Basilea Secures $39 Million BARDA Funding to Advance Novel Antifungal Candidates Fosmanogepix and BAL2062
去年
Basilea Launches Phase 3 Trial for Novel Antifungal Fosmanogepix in Invasive Mold Infections
2年前
T2 Biosystems' T2Candida Panel Receives FDA Clearance for Pediatric Use
上个月
Basilea Secures $30 Million BARDA Tranche to Advance Fosmanogepix Phase III Program for Invasive Fungal Infections
去年
Rezafungin Shows Promise in Treatment of Severe Candidemia, Offering Weekly Dosing Alternative
2个月前
Invasive Fungal Infections Market Poised for Robust Growth by 2036 as Novel Broad-Spectrum Antifungals Advance Through Pipeline
8个月前
SCYNEXIS Receives FDA Fast Track and QIDP Designations for SCY-247 Antifungal Therapy
去年
SCYNEXIS Presents Promising Data on SCY-247 Against Drug-Resistant Fungal Infections at TIMM-12 Congress
第 1 页,共 258 页
上一页
下一页